News | January 22, 2013

Clinical Decision Support Aids Pediatric Cardiac Diagnoses

Software can be used to screen in real time when an expert is not present

January 22, 2013 — Peri-natal systems real-time clinical decision support company PeriGen Inc. announced the results of an independent validation study on fetal ECG strip interpretation favorably comparing PeriGen PeriCALM Patterns software with the findings of three experts from the National Institute of Health (NIH). The U.S. Food and Drug Administration (FDA)-cleared fetal strip interpretation technology is a component of the company's perinatal central surveillance offering.

The study reviewed the analysis of PeriCALM Patterns during the final hour of 100 tracings, and concluded that, "computerized fetal heart rate interpretation has substantial agreement with experts' evaluation. The software can be used to efficiently evaluate stored fetal heart rate data retrospectively as well as to screen in real time when an expert is not continuously evaluating the fetal heart rate," as reported by Steven Wiener of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, Maternal-Fetal Medicine Units Network, Bethesda, Md. In over 97 percent of the assessments, the experts agreed with the analysis by PeriCALM Patterns.

This validation study is the first phase of a research collaboration announced earlier in 2012, Computerized Interpretation of Intrapartum FHR and Prediction of Neonatal Outcomes, with primary investigators George R. Saade, M.D., University of Texas Medical Branch in Galveston, Texas, and Sean Blackwell, M.D., University of Texas at Houston-Children's Memorial Hermann Hospital. The findings will be presented at the Annual Clinical Meeting of the Society of Maternal Fetal Medicine (SMFM) in San Francisco on Feb. 16, 2013 and were published in the American Journal of Obstetrics and Gynecology, Vol. 208, Issue 1, Supplement S316-S317.

"We are delighted by the results," commented Emily Hamilton, senior vice president of Clinical Research, PeriGen. "Internationally recognized experts participated in this extensive and completely independent test. These results demonstrate that clinicians can have confidence in the use of PeriCALM at the bedside. In addition, other researchers can rely upon the software to consistently analyze thousands of tracings retrospectively and test new scientific hypotheses to clarify what combination of FHR features are truly indicative of impending birth related hypoxic injury."

"PeriCALM Patterns from PeriGen provides far more clinical insight than other central perinatal surveillance systems into what is arguably the most subjective and highest risk task in delivering a baby — interpreting the fetal monitoring strip," said PeriGen CEO Matthew Sappern. "The incremental insight provided by PeriCALM Patterns means better information for making clinical decisions and promoting improved outcomes."

For more information: www.nichd.nih.gov, www.smfm.org, www.PeriGen.com

Related Content

OTC ECG devices

OTC ECG devices can help detect abnormal heart rhythms in the general population, and this technology will continue to improve.

Feature | ECG | March 11, 2020
Apple created a stir when it...
Several wearable, less-obtrusive ECG monitors fhave been cleared by the FDA for longer wear. This example is Cardiac Insight’s Cardea SOLO device. 

Several wearable, less-obtrusive ECG monitors have been cleared by the FDA for longer wear. This example is Cardiac Insight’s Cardea SOLO device. 

Feature | ECG | February 19, 2020
When the patients of Michael Boler, M.D. need cardiac monitoring, the Holter monitor is no longer his first choice. “...
The Bittium Faros uses a 4-in-1 ECG technology. It is a lightweight, waterproof and can be configured for different patient monitoring needs. Bittium Faros Holter monitoring.

The Bittium Faros uses a 4-in-1 ECG technology. It is a lightweight, waterproof and can be configured for different patient monitoring needs. 
 

News | ECG | January 22, 2020
January 22, 2020 – Bittium is exhibiting solutions for cardiology at...
Cardiologs
News | ECG | December 12, 2019
December 12, 2019 — Cardiologs, a global leader in artificial intelligence (AI)
FDA Clears AliveCor's KardiaMobile 6L as First Six-Lead Personal ECG Device
Technology | ECG | May 13, 2019
AliveCor announced its third U.S. Food and Drug Administration (FDA) clearance in three months, making KardiaMobile 6L...
One innovation in ECG is its use in the customer wearable market, which will tie more closely into the clinical world either with using the data to triage patients and/or patients seeking medical attention prior to acute symptoms appearing.

One innovation in ECG is its use in the customer wearable market, which will tie more closely into the clinical world either with using the data to triage patients and/or patients seeking medical attention prior to acute symptoms appearing.

Feature | ECG | May 03, 2019 | Sanket Solanki
Technology has made its way into the healthcare sector and brought a drastic transformation.
Videos | ECG | March 05, 2019
This is a quick demo of the Schiller Cardiovit FT-1 electrocardiograph (ECG) system displayed at the ...
EKG With Artificial Intelligence Reliably Detects Heart Failure Precursor
News | ECG | January 08, 2019
January 8, 2019 — A Mayo Clinic study finds that applying...
Use of traditional Holter monitor leads can be an issue for patient compliance and comfort. The newer generation ambulatory cardiac monitors use an adhesive patch that sticks directly on the patient's chest and allows them to shower and go about daily activities without a belt mounted monitor or leads getting in the way. This is especially important for longer term monitoring of seven days or longer.

Use of traditional Holter monitor leads can be an issue for patient compliance and comfort. The newer generation ambulatory cardiac monitors use a small, adhesive patch that sticks directly on the patient's chest and allows them to shower and go about daily activities without a belt mounted monitor or leads getting in the way. This is especially important for longer term monitoring of seven days or longer. 

Feature | ECG | September 27, 2018
Advances in the technology of wearable cardiac monitors are improving both the experience of the patient and the effe
HeartSciences MyoVista ECG Device Shows Promise in Detecting Abnormal Cardiac Function
News | ECG | April 27, 2018
HeartSciences announced the results of a clinical study of its electrocardiography device that applies continuous...